AlphaStocks
5.2
Consider Buy

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Health Care / Health Care Equipment

S&P SmallCap 600

$18.02

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#487out of 1121 in Health Care

Is INTEGRA LIFESCIENCES HOLDINGS CORP a Good Investment in 2026?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates INTEGRA LIFESCIENCES HOLDINGS CORP as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 92%). INTEGRA LIFESCIENCES HOLDINGS CORP currently trades below its estimated fair value of $24, suggesting potential upside. INTEGRA LIFESCIENCES HOLDINGS CORP ranks #487 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-38.7Market Cap1B

Estimated Fair Value

$24.0225% below

Fair value above market price — fundamentals support a higher valuation.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 92%)

Frequently Asked Questions

Is INTEGRA LIFESCIENCES HOLDINGS CORP (IART) a good investment?
Based on AlphaStocks' composite analysis, INTEGRA LIFESCIENCES HOLDINGS CORP (IART) scores 5.2 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Fair value above market price — fundamentals support a higher valuation.
What is INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-Score?
INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is IART overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $24, IART appears undervalued. The stock currently trades 25% below its estimated fair value. Fair value above market price — fundamentals support a higher valuation.
How does IART compare to other Health Care stocks?
INTEGRA LIFESCIENCES HOLDINGS CORP ranks #487 out of 1121 stocks in the Health Care sector, placing it in the top 43% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about IART?
AlphaStocks evaluates IART using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.2/10.

Similar Stocks

PARRBFAMAZN

Compare IART with

IART vs PARRIART vs BFAMIART vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer